VR Adviser, LLC

SEC CIK: 0001615982
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by VR Adviser, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of CRVS by VR Adviser, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−250,000−100.0%	Sold out	Holders
Q4 2021	250,000	$603.0K	0.1%	−3,177,461−92.7%	Reduced	Holders
Q3 2021	3,427,461	$16.6M	2.1%	+3,427,461	New	Holders